Physician profile
Michael J Brown
NPI 1003865304
$1,822.88
in general payments reported to CMS, 2019-2025
15 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.91 · 2020: $41.56 · 2021: $411 · 2022: $121 · 2023: $417 · 2024: $411 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $486.92 | 2022-2025 | Nucala |
| Stryker Corporation | $310.52 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $284.57 | 2021-2025 | Dupixent |
| Optinose US, INC. | $211.32 | 2022-2024 | |
| 3nt Medical | $116.67 | 2024 | |
| Smith+Nephew, INC. | $93.07 | 2023 | Tula |
| Integra Lifesciences Corporation | $71.49 | 2021-2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Genzyme Corporation | $56.66 | 2024-2025 | |
| Alk-Abello, INC | $48.96 | 2021-2023 | Timothy, Standardized, Standardized Mite D. Farinae, Histamine Positive |
| Inspire Medical Systems, INC. | $43.17 | 2023-2025 | Inspire |
| Covidien LP | $31.07 | 2019 | |
| Precigen, INC. | $19.12 | 2025 | |
| Aerin Medical INC. | $18.81 | 2023 | |
| Sanofi-Aventis U.S. LLC | $16.31 | 2021 | |
| Neurent Medical Limited | $14.22 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.